Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia

{ 'indexed': {'date-parts': [[2024, 2, 29]], 'date-time': '2024-02-29T12:01:17Z', 'timestamp': 1709208077664}, 'reference-count': 8, 'publisher': 'Elsevier BV', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2021, 2, 1]], 'date-time': '2021-02-01T00:00:00Z', 'timestamp': 1612137600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2020, 9, 22]], 'date-time': '2020-09-22T00:00:00Z', 'timestamp': 1600732800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.fr', 'clinicalkey.com.au', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2021, 2]]}, 'DOI': '10.1016/j.jmii.2020.09.003', 'type': 'journal-article', 'created': {'date-parts': [[2020, 10, 5]], 'date-time': '2020-10-05T16:33:55Z', 'timestamp': 1601915635000}, 'page': '109-112', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 9, 'title': 'Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia', 'prefix': '10.1016', 'volume': '54', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-1433-0276', 'authenticated-orcid': False, 'given': 'Nobuaki', 'family': 'Mori', 'sequence': 'first', 'affiliation': []}, {'given': 'Mitsuya', 'family': 'Katayama', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shigenari', 'family': 'Nukaga', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.jmii.2020.09.003_bib1', 'doi-asserted-by': 'crossref', 'first-page': '497', 'DOI': '10.1016/S0140-6736(20)30183-5', 'article-title': 'Clinical features of patients infected with 2019 novel coronavirus in ' 'Wuhan, China', 'volume': '395', 'author': 'Chaolin', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.jmii.2020.09.003_bib2', 'doi-asserted-by': 'crossref', 'unstructured': 'Taccone FS, Gorham J, Jean-Louis Vincent. Hydroxychloroquine in the ' 'management of critically ill patients with COVID-19: the need for an ' 'evidence base Comment. The Lancet Respiratory. ' 'https://doi.org/10.1016/S2213-2600(20)30172-7.', 'DOI': '10.1016/S2213-2600(20)30172-7'}, { 'key': '10.1016/j.jmii.2020.09.003_bib3', 'doi-asserted-by': 'crossref', 'first-page': '2411', 'DOI': '10.1056/NEJMoa2012410', 'article-title': 'Observational study of hydroxychloroquine in hospitalized patients with ' 'Covid-19', 'volume': '382', 'author': 'Joshua', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.jmii.2020.09.003_bib4', 'doi-asserted-by': 'crossref', 'first-page': '105949', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'volume': '56', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.jmii.2020.09.003_bib5', 'article-title': 'The inhaled corticosteroid ciclesonide blocks coronavirus RNA ' 'replication by targeting viral NSP15', 'author': 'Matsuyama', 'year': '2020', 'journal-title': 'Biorxivorg'}, { 'key': '10.1016/j.jmii.2020.09.003_bib6', 'first-page': '1824', 'article-title': 'Pharmacologic treatments for coronavirus disease 2019 (COVID-19)', 'volume': '323', 'author': 'Sanders', 'year': '2020', 'journal-title': 'J Am Med Assoc'}, { 'key': '10.1016/j.jmii.2020.09.003_bib7', 'article-title': 'Infectious diseases society of America guidelines on the treatment and ' 'management of patients with COVID-19', 'author': 'Bhimraj', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.jmii.2020.09.003_bib8', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fimmu.2018.00302', 'article-title': 'The immunomodulatory effects of macrolides—a systematic review of the ' 'underlying mechanisms', 'volume': '9', 'author': 'Zimmermann', 'year': '2018', 'journal-title': 'Front Immunol'}], 'container-title': 'Journal of Microbiology, Immunology and Infection', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1684118220302371?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1684118220302371?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2021, 2, 21]], 'date-time': '2021-02-21T14:09:06Z', 'timestamp': 1613916546000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1684118220302371'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 2]]}, 'references-count': 8, 'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2021, 2]]}}, 'alternative-id': ['S1684118220302371'], 'URL': 'http://dx.doi.org/10.1016/j.jmii.2020.09.003', 'relation': {}, 'ISSN': ['1684-1182'], 'subject': [], 'container-title-short': 'Journal of Microbiology, Immunology and Infection', 'published': {'date-parts': [[2021, 2]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for ' 'COVID-19 pneumonia', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Journal of Microbiology, Immunology and Infection', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.jmii.2020.09.003', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.', 'name': 'copyright', 'label': 'Copyright'}]}